Hydroxyurea Pharmacokinetics for Predicting Maximum Tolerated Dose in Children with Sickle Cell Anemia

被引：0
|
作者：
McGann, Patrick T. [1 ]
Sparreboom, Alex [2 ]
Mortier, Nicole A. [1 ]
Aygun, Banu [3 ]
Howard, Thad A. [1 ]
Nottage, Kerri [2 ]
Ware, Russell E. [1 ]
机构：
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[3] Steven & Alexandra Cohen Childrens Med Ctr, New York, NY USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia
    McGann, Patrick T.
    Dong, Min
    Ware, Russell E.
    Vinks, Alexander A.
    [J]. BLOOD, 2015, 126 (23)
  • [2] Prognostic Factors for Hospitalization of Children with Sickle Cell Anemia Treated with Hydroxyurea at Maximum Tolerated Dose
    Estepp, Jeremie H.
    Huang, Qinlei T.
    Wang, Winfred C.
    Kang, Guolian
    [J]. BLOOD, 2015, 126 (23)
  • [3] Hydroxyurea pharmacokinetics in children with sickle cell anemia
    Harrod, Virginia L.
    Sparreboom, Alex
    Nicole, Mortier
    Susan, Strawn
    Howard, Thad
    Ware, Russell E.
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 613 - 613
  • [4] A RANDOMIZED CONTROLLED TRIAL OF A DOSE-PREDICTION EQUATION TO DETERMINE MAXIMUM TOLERATED DOSE OF HYDROXYUREA IN CHILDREN WITH SICKLE CELL ANEMIA
    George, Alex
    Aygun, Banu
    Mortier, Nicole
    Sparreboom, Alex
    Ware, Russell
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : S32 - S32
  • [5] "Maximum tolerated dose" vs "fixed low-dose" hydroxyurea for treatment of adults with sickle cell anemia
    Akingbola, Titilola S.
    Tayo, Bamidele O.
    Ezekekwu, Chinedu A.
    Sonubi, Omowunmi
    Zhang, Xu
    Saraf, Santosh L.
    Molokie, Robert
    Hsu, Lewis L.
    Han, Jin
    Cooper, Richard S.
    Gordeuk, Victor R.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (04) : E112 - E115
  • [6] Higher Fetal Hemoglobin Following Escalation of Hydroxyurea to Maximum Tolerated Dose Provides Clinical Benefit to Children with Sickle Cell Anemia
    Estepp, Jeremie H.
    Smeltzer, Matthew P.
    Kang, Guolian
    Aygun, Banu
    Ware, Russell E.
    Nottage, Kerri
    [J]. BLOOD, 2014, 124 (21)
  • [7] Predicting Hydroxyurea Responses in Children with Sickle Cell Anemia
    Ware, Russell E.
    Mortier, Nicole A.
    Smeltzer, Matthew P.
    Howard, Thad A.
    Kimble, Amy C.
    Despotovic, Jenny M.
    Wu, Song
    Aygun, Banu
    Flanagan, Jonathan Michael
    Sparreboom, Alex
    [J]. BLOOD, 2011, 118 (21) : 933 - 934
  • [8] Computer Algorithm-Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell Anemia
    Oldham, Mahogany
    Conrey, Anna
    Pittman, Corinne
    Fisher, Cameron
    Hargrett, Simone
    West, Kamille
    Jackson, Mary
    Martin, Staci
    Hsieh, Matthew M.
    Jeffries, Neal
    Kaplarevic, Mihailo
    Johnson, Dachelle
    Olkhanud, Purevdorj
    Fitzhugh, Courtney D.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (01): : 41 - 51
  • [9] Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
    Mack, Joana Marie
    Wiczling, Pawel
    Moen, Joseph
    Kang, Guolian
    Liem, Robert I.
    Panepinto, Julie A.
    Kearns, Gregory
    Neville, Kathleen A.
    Estepp, Jeremie H.
    [J]. BLOOD, 2016, 128 (22)
  • [10] Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease
    Zimmerman, SA
    Schultz, WH
    Davis, JS
    Pickens, CV
    Mortier, NA
    Howard, TA
    Ware, RE
    [J]. BLOOD, 2004, 103 (06) : 2039 - 2045
12345